Nospin heparg (8.0M cells / vial)
Ended Awarded
- Contract number
- 75N95C22F00001
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,861
Award facts
- Contract value 100% obligated
- $24,860.60 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95C22F00001?
75N95C22F00001 was awarded to Lonza Walkersville, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on September 12, 2022.
How much is contract 75N95C22F00001 worth?
The government has obligated $24,861 on 75N95C22F00001.
Is contract 75N95C22F00001 an order under another contract?
Yes. 75N95C22F00001 is a BPA call under HHSN263201600052B, a blanket purchase agreement.
Was contract 75N95C22F00001 competed?
The extent of competition for 75N95C22F00001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award